STUDY COMPARISON OF EFFICACY OF LEVETIRACETAM ANDMAGNESIUM SULPHATE IN THE MANAGEMENT OF ANTEPARTUM, INTRAPARTUM AND POSTPARTUM CONVULSIONS
Phase 2/3
Not yet recruiting
- Conditions
- Eclampsia, unspecified as to timeperiod,
- Registration Number
- CTRI/2021/04/032963
- Lead Sponsor
- Dr Sindhu Manne
- Brief Summary
If the drug Levetiracetam can be proven to be as effective as magnesium sulphate and relatively safe in patients than further continued assessment and use of the drug can be done.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Female
- Target Recruitment
- 76
Inclusion Criteria
ALL PATIENTS PRESENTING WITH FEATURES OF ECLAMPSIA DURING THE SAID PERIOD WILL BE RECRUITED INTO THE STUDY ALL PATIENTS GIVING INFORMED AND WRITTEN CONSENT FOR INVESTIGATIONS.
Exclusion Criteria
PATIENTS WHO WERE DIAGNOSED WITH OTHER CAUSES OF CONVULSIONS IN PREGNANCY LIKE CEREBRAL MALARIA AND EPILEPSY CHRONIC HYPERTENSIVE PREGNANT FEMALES PREGNANT FEMALES WITH FETAL ANOMALIES DETECTED ON USG.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method TO OBSERVE FOR CONVULSIONS POST ANTIEPILEPTIC TREATMENT DURING THE PERIOD PATIENT IS IN HOSPITAL DURATION OF HOSPITAL STAY (1-2 WEEKS)
- Secondary Outcome Measures
Name Time Method NOT APPLICABLE NOT APPLICABLE
Trial Locations
- Locations (1)
Shri BM Patil Medical College and Research Center
🇮🇳Bijapur, KARNATAKA, India
Shri BM Patil Medical College and Research Center🇮🇳Bijapur, KARNATAKA, IndiaSINDHU MANNEPrincipal investigator9553223311smanne521@gmail.com